Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 398 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
NEW PERSPECTIVE
Year : 2015  |  Volume : 5  |  Issue : 2  |  Page : 157-158

Phentermine-topiramate: First combination drug for obesity


Department of Pharmacology, Government Medical College and Hospital, Chandigarh, India

Correspondence Address:
Jagjit Singh
Department of Pharmacology, Government Medical College ans Hospital, Chandigarh - 160 030
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2229-516X.157177

Rights and Permissions

Obesity is spreading globally at an alarming speed. The management of obesity is multifaceted and includes lifestyle modifications as the cornerstone. Until only orlistat was approved for long term use in obesity. The US Food and Drug Administration granted approval to a fixed dose mid 2012 combination of phentermine immediate release and topiramate extended release in 2012 for treatment of obese patients or overweight patients with comorbid conditions. The new drug has shown significant weight loss compared with placebo for a period up to 2 years.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4947    
    Printed39    
    Emailed2    
    PDF Downloaded506    
    Comments [Add]    
    Cited by others 7    

Recommend this journal